drugset / Trial / NCT00244166

Prednisolone in Active Ankylosing Spondylitis (AS)

NCT00244166 ↗

Phase 2/3 Unknown 75 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupDouble-blindTreatment

Summary

1. to investigate whether steroids are effective in ankylosing spondylitis 2. if steroids are effective to describe how quick they work

Timeline

Start
2002-05
Primary completion
—
Completion
2008-08

Outcome

Missed primary endpoint

paper (p=0.16 and p=0.30) PMID 23625982 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 20 mg Oral
Subject Prednisolone Other / unclassified 50 mg Oral